Stay updated on Cabozantinib in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Solid Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the completed cabozantinib study is displayed with its study details, eligibility criteria, treatment plan, and results, instead of a 403 error screen.SummaryDifference44%

- Check18 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide announcement says NIH websites are changing and that some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now shows a 403 Forbidden error screen with an HTML skeleton and navigation, replacing the study record content. This indicates an access/availability issue rather than a substantive content update to the study listing.SummaryDifference17%

Stay in the know with updates to Cabozantinib in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.